SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Lupus/Nephritis
An SI Board Since March 2001
Posts SubjectMarks Bans
95 18 0
Emcee:  keokalani'nui Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
45As you probably know, GL701 is DHEA. IMO, FDA is just trying to find any reasonscaram(o)uche-8/30/2002
44Aslera. Press Release Source: Genelabs Technologies, Inc. Genelabs Receives Akeokalani'nui-8/30/2002
43Active Biotech has Selected a New Candidate Drug for the Treatment of Lupus LUNDkeokalani'nui-6/25/2002
42Lupus In a finding that could lead to better treatments for lupus, a Princetonmichael_f_murphy-4/24/2002
41[LJP 394 Presentations] La Jolla Pharmaceutical Scientists Present at Two Interkeokalani'nui-2/25/2002
40<i>Linda Nardone, Ph.D., RAC Vice President of Clinical and Regulatory Affscaram(o)uche-1/30/2002
39EluSys Begins Trials of Heteropolymer in Humans; First Use of HP System in Humannigel bates-1/28/2002
38Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Aukeokalani'nui-12/19/2001
37Really interesting. <i>>>The analyses, he said, revealed that dendrkeokalani'nui-11/15/2001
36Researchers at UT Southwestern Medical Center at Dallas and the Baylor Institutenigel bates-11/15/2001
35NEW YORK (Reuters Health) - Scientists announced on Wednesday that they may havenigel bates-11/1/2001
34Human Genome Sciences Initiates Trial of a New Drug for Systemic Lupus Erythematnigel bates-11/1/2001
33Thanks Mark. Biogen disovers new b-cell receptor. Message 16221083keokalani'nui-8/16/2001
32FDA Notifies Genelabs That Aslera(TM) NDA is Not Approvable Genelabs Will Work wkeokalani'nui-6/27/2001
31Site showing drugs in development for lupus and availability of clinical trials.keokalani'nui-5/14/2001
30And the association between MAC and disease activity: 1: Clin Immunol Immunopatkeokalani'nui-5/7/2001
29To the question whether anti-C5 might benefit (SLE) patients with renal disease:keokalani'nui-5/7/2001
28From the Pink Sheets, re Aslera: Genelabs Aslera Postmarketing Safety Study forkeokalani'nui-5/6/2001
27That is interesting. And sure doesn't feel right for the advertiser. A perkeokalani'nui-5/5/2001
26When driving home heard a commercial on New York's biggest AM newsstation (Whmpa-5/4/2001
25This development (new costimulatory pathway) may be worth watching. Wasn't keokalani'nui-5/4/2001
24LJPC. anti-dsDNA. I just read the Furie m/s on the PII 58 pt trial, which by tkeokalani'nui-4/25/2001
23Rick. There is much in your message to gnaw on. Thank you. I've been in ankeokalani'nui-4/24/2001
22This sort of observation could be a trap. Remitting disease. How do we know thscaram(o)uche-4/24/2001
21: Ann Rheum Dis 2001 May;60(5):523-6 Related Articles, Books, LinkOut Expresskeokalani'nui-4/24/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):